Use of Potentially Impairing Medications in Relation to Driving, United States, 2021
archive: archived pipeline: cataloged verified
Get this paper ↗ (full text — opens at the source; we link to it, we don't host it)
Summary
This study investigates the prevalence of recent use of potentially driver impairing (PDI) medications among U.S. drivers and assesses the relationship between healthcare provider warnings and driving behavior. Motivated by the fact that many prescription and over-the-counter medications cause side effects such as dizziness, sleepiness, and blurred vision, the research aims to quantify how often drivers use these substances and whether professional counseling reduces the likelihood of driving shortly after ingestion. The analysis utilized data from the 2021 Traffic Safety Culture Index, a national online survey administered in English and Spanish. The final sample consisted of 2,657 licensed drivers aged 16 and older who had driven in the preceding 30 days. Respondents reported use of six medication classes—antihistamines/cough medicines, antidepressants, prescription pain medications, muscle relaxants, sleep aids/benzodiazepines, and amphetamines—within the past month. For each medication used, participants indicated if they drove within two hours of use and whether a healthcare provider had warned them about potential driving impairment. Statistical analyses included crosstabulations and Poisson regression to adjust for demographic factors and driving frequency. Results indicated that approximately 50% of drivers used at least one PDI medication in the past 30 days, with antihistamines and cough medicines being the most common (33.5%). Nearly one in five drivers used two or more such medications. Among those who used PDI medications, 45% reported driving within two hours of use; this proportion rose to 70.8% for those using three or more medications. Amphetamine users had the highest rate of post-use driving (73.1%). Regarding counseling, warning rates varied by medication type, ranging from 50.2% for antihistamines to 79.7% for sleep aids. Crucially, drivers who received a warning from a healthcare provider were 18% less likely to drive within two hours of taking a prescribed medication (Incidence Rate Ratio = 0.82). This protective effect was statistically significant for antidepressants, pain medications, and muscle relaxants, but not for sleep aids or amphetamines. The findings highlight a significant gap in patient education, as 20% to 50% of drivers using prescribed PDI medications reported receiving no warning about driving risks. The study concludes that while healthcare provider counseling effectively reduces medication-impaired driving, current practices are inadequate. The authors recommend that providers consistently counsel patients on driving risks, particularly for older adults who may be more susceptible to impairment due to comorbidities or drug interactions. Additionally, they suggest reducing prescriptions of PDI medications where safer alternatives exist. The study acknowledges limitations, including self-reporting bias and the inability to distinguish between impairment caused by the medication versus the underlying medical condition.
Key finding
Drivers who received warnings from healthcare providers about the potential for medications to impair driving were 18% less likely to drive within two hours of taking the medication compared to those who did not receive such warnings.
Methodology
survey
Sample size: 2657
Provenance
The full processing record for this entry. Every stage of this paper's journey through the pipeline is logged — what ran, with which tool and model, how many attempts it took, and when it last completed. Discovered via bulk_ingest_aaa_foundation on 2026-05-23 (6 acquisition events logged).
| Stage | Outcome | Tool | Model | Prompt | Attempts | Completed |
|---|---|---|---|---|---|---|
| discover | success | aaa_foundation | — | — | 2 | 2026-05-23 |
| archive | success | — | — | — | 1 | 2026-05-23 |
| extract | success | cached | — | — | 2 | 2026-06-10 |
| clean | success | — | — | — | 1 | 2026-06-01 |
| chunk | success | — | — | — | 1 | 2026-06-01 |
| embed | success | — | — | — | 1 | 2026-06-02 |
| enrich | success | — | — | — | 1 | 2026-05-23 |
| promote | success | — | — | — | 1 | 2026-05-23 |
| summarize | success | llm | qwen3.6-27b-prismaquant | summ-v5 | 3 | 2026-06-10 |
| tag | success | vector_similarity | — | — | 19 | 2026-06-11 |
| verify | partial | — | — | — | 2 | 2026-06-10 |
Summary generated by qwen3.6-27b-prismaquant on 2026-06-10; verification: verified_with_issues.
Topics
Ranked by relevance to this paper. Hover a topic for its definition.
Information type
What kind of knowledge this paper contributes, grouped by family — independent of topic (what it is about) and method (how it was studied).
- Empirical Findings: observational prevalence